Drug profile · INN
octreotide
OCTREOTIDE (SUN)
octreotide (OCTREOTIDE (SUN)) is a somatostatin receptor agonist. Associated with Novartis Pharmaceuticals.
EMA: approved TGA: approved NMPA: clinical trials Systemic hormonal preparations (H01) H01CB02
Patents linked 0
Pipeline programs 13
News articles 0
Drug details — octreotide
- Class
- Systemic hormonal preparations (H01)
- Route
- —
- Patents
- 0
- Programs
- 13
- Data quality
- 0.83
Quick answer
octreotide (OCTREOTIDE (SUN)) is a somatostatin receptor agonist. Associated with Novartis Pharmaceuticals.
Key facts
INN octreotide
Brand OCTREOTIDE (SUN)
Mechanism Somatostatin receptor agonist
Therapeutic class Systemic hormonal preparations (H01)
ATC code H01CB02
Originator Novartis Pharmaceuticals
Mechanism of action
Somatostatin receptor agonist
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is octreotide?
octreotide (OCTREOTIDE (SUN)) is a somatostatin receptor agonist. Associated with Novartis Pharmaceuticals.
What is the brand name for octreotide?
OCTREOTIDE (SUN) is a marketed brand name for octreotide. Check FDA Drugs@FDA for the current US label holder and prescribing information.